Provectus Pharmaceuticals Completes Patient Accrual in Phase 2C Clinical Trial of PH-10 for Psoriasis
Provectus Pharmaceuticals Completes Patient Accrual in Phase 2C Clinical Trial of PH-10 for Psoriasis
KNOXVILLE, Tenn.–(BUSINESS WIRE)–Provectus Pharmaceuticals has completed patient accrual in its Phase 2C clinical trial of PH-10 for psoriasis.
Read more on Business Wire
Categories: Breast Cancer Information Tags: Accrual, Clinical, Completes, patient, PH10, Pharmaceuticals, Phase, Provectus, Psoriasis, Trial
Tigris Pharmaceuticals, Inc. Completes $6.5 Million Private Placement
Tigris Pharmaceuticals, Inc. Completes $6.5 Million Private Placement
Tigris Pharmaceuticals, Inc., a privately held drug development company, announced today that it has completed a private placement of Series C Convertible Preferred Stock resulting in gross proceeds of approximately $6.5 million. Â The financing, which was led by Mr.
Read more on PR Newswire via Yahoo! Finance
Categories: High Risk Breast Cancer Tags: $6.5, Completes, Inc., million, Pharmaceuticals, Placement, private, Tigris
Provectus completes enrollment in first cohort of PV-10 Phase 1 trial for liver cancer
Provectus completes enrollment in first cohort of PV-10 Phase 1 trial for liver cancer
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has completed enrollment in the first of two dose cohorts in its Phase 1 clinical trial of PV-10 for liver cancer, and that the therapy was very well tolerated by all three subjects treated, with substantial evidence of efficacy.
Read more on News-Medical-Net
Categories: Breast Cancer In Men Tags: cancer, cohort, Completes, enrollment, first, liver, Phase, Provectus, PV10, Trial
Hologic Completes Acquisition of Sentinelle Medical
Hologic Completes Acquisition of Sentinelle Medical
Hologic, Inc. , a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the completion of its acquisition of Sentinelle Medical Inc. , a leading provider of Magnetic Resonance Imaging breast coils, tables and visualization software.
Read more on PR Newswire via Yahoo! Finance
Categories: High Risk Breast Cancer Tags: Acquisition, Completes, Hologic, Medical, Sentinelle
Guthrie scholar completes program
Guthrie scholar completes program
Morning Times SAYRE — Maryana Yevtukh, senior pre-med major at Wilkes University in Wilkes-Barre, Pa., recently completed the Guthrie Scholars Program.
Read more on Morning Times
Categories: Breast Cancer Information Tags: Completes, Guthrie, program, Scholar
Cellceutix Completes All Three Animal Safety Pharmacology Studies for Its Cancer Compound Required by FDA Prior to …
Cellceutix Completes All Three Animal Safety Pharmacology Studies for Its Cancer Compound Required by FDA Prior to …
BEVERLY, MA–(Marketwire – 07/07/10) – Cellceutix Corporation (OTC.BB: CTIX – News ) today announced that it has completed all three animal safety pharmacology studies for its cancer compound, Kevetrin, that are required by the U. S. Food and Drug Administration prior to filing an IND. These studies involve assessments of the impact of the administration of a compound on the respiratory …
Read more on Marketwire via Yahoo! Finance
Categories: Breast Cancer Risks Tags: animal, cancer, Cellceutix, Completes, compound, Pharmacology, prior, required, Safety, Studies, three
Fiorina Completes Reconstructive Surgery
Fiorina Completes Reconstructive Surgery
Republican Senate candidate Carly Fiorina on Tuesday completed reconstructive surgery following her battle with breast cancer. Fiorina is resting after completing her final surgery, according to a statement released by her chief of staff Deborah Bowker.
Read more on CBS 5 Bay Area
Categories: Breast Cancer Radiation Tags: Completes, Fiorina, reconstructive, surgery
Biomoda Completes Patient Enrollment and Sample Collection in Pilot Study
Biomoda Completes Patient Enrollment and Sample Collection in Pilot Study
ALBUQUERQUE, N.M.—-Cancer diagnostics company Biomoda, Inc. today announced it completed patient enrollment and sample collection in a pilot study to determine the clinical sensitivity and specificity of its CyPath® labeling solution for the early detection of lung cancer.
Read more on Business Wire via Yahoo! Finance
Categories: Breast Cancer Screening Tags: Biomoda, Collection, Completes, enrollment, patient, Pilot, Sample, Study
OXiGENE completes enrollment in ZYBRESTAT Phase 2 FALCON trial for NSCLC
OXiGENE completes enrollment in ZYBRESTAT Phase 2 FALCON trial for NSCLC
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it has completed its targeted enrollment of 60 patients in the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT™ in patients with non-squamous non-small cell lung cancer (NSCLC).
Read more on News-Medical-Net
Categories: Metastatic Breast Cancer Tags: Completes, enrollment, FALCON, NSCLC, OXiGENE, Phase, Trial, ZYBRESTAT
Cellceutix Completes Successful Pre-IND Meeting With FDA For Cancer Drug
Cellceutix Completes Successful Pre-IND Meeting With FDA For Cancer Drug
Cellceutix Corporation (OTCBB: CTIX), a bio-pharmaceutical company that develops small molecules to treat cancer and inflammatory disease, announced that is has completed a successful pre-Investigational New Drug exemption (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) for its lead compound, Kevetrin, which is being developed to treat drug resistant cancers. The Company has …
Read more on Medical News Today
Categories: Breast Cancer Staging Tags: cancer, Cellceutix, Completes, drug, Meeting, PreIND, Successful